APA

Skarlos P., Christodoulou C., Kalogeras K. T., Eleftheraki A. G., Bobos M., Batistatou A., Valavanis C., Tzaida O., Timotheadou E., Kronenwett R., Wirtz R. M., Kostopoulos I., Televantou D., Koutselini E., Papaspirou I., Papadimitriou C. A., Pectasides D., Gogas H., Aravantinos G., Pavlidis N., Arapantoni P., Skarlos D. V. & Fountzilas G. (20120320). Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial. : Cancer chemotherapy and pharmacology.

Chicago

Skarlos P, Christodoulou C, Kalogeras K T, Eleftheraki A G, Bobos M, Batistatou A, Valavanis C, Tzaida O, Timotheadou E, Kronenwett R, Wirtz R M, Kostopoulos I, Televantou D, Koutselini E, Papaspirou I, Papadimitriou C A, Pectasides D, Gogas H, Aravantinos G, Pavlidis N, Arapantoni P, Skarlos D V and Fountzilas G. 20120320. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial. : Cancer chemotherapy and pharmacology.

Harvard

Skarlos P., Christodoulou C., Kalogeras K. T., Eleftheraki A. G., Bobos M., Batistatou A., Valavanis C., Tzaida O., Timotheadou E., Kronenwett R., Wirtz R. M., Kostopoulos I., Televantou D., Koutselini E., Papaspirou I., Papadimitriou C. A., Pectasides D., Gogas H., Aravantinos G., Pavlidis N., Arapantoni P., Skarlos D. V. and Fountzilas G. (20120320). Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial. : Cancer chemotherapy and pharmacology.

MLA

Skarlos P, Christodoulou C, Kalogeras K T, Eleftheraki A G, Bobos M, Batistatou A, Valavanis C, Tzaida O, Timotheadou E, Kronenwett R, Wirtz R M, Kostopoulos I, Televantou D, Koutselini E, Papaspirou I, Papadimitriou C A, Pectasides D, Gogas H, Aravantinos G, Pavlidis N, Arapantoni P, Skarlos D V and Fountzilas G. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial. : Cancer chemotherapy and pharmacology. 20120320.